"...no reply to date"
Not STX or Board/Stu's job to follow up on these sorts of issues. They have an exciting business proposition in front of them - Execute strategy and run it profitably for us shareholders. They must however choose wisely on who their Strategic partners are for:
1. Capital/Funding
2. Confidential Advice & Commercial in confidence discussions
3. JV growth opportunities.
Allegedly, however, there is an "integrated corporate, markets, financial services and consumer credit regulator that is an Independant Australian Govt body" responsible for looking into this..............at least that's what it says on the tin label.
If this entity strengthened financial market integrity in 2023:
https://asic.gov.au/regulatory-resources/find-a-document/reports/rep-780-asic-enforcement-and-regulatory-update-october-to-december-2023/
- ANZ Bank (failure to disclose activities)
- Banned Peter John Collins from leveraging insider information at PWC
- Court found someone and her associates guilty of failing to disclose a relevant share ownership, interest & relationship in a Company (Corporations Act)................Hmmmm.
- Market Share price Manipulation (Eneco Refresh, EverBlu, CresoPharma)
Then one would think this Independant entity should have some momentum to go on a bear hunt.
- Forums
- ASX - By Stock
- Eregulla Deeps
"...no reply to date"Not STX or Board/Stu's job to follow up on...
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add STX (ASX) to my watchlist
|
|||||
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $487.1M |
Open | High | Low | Value | Volume |
17.5¢ | 17.5¢ | 16.3¢ | $2.306M | 13.66M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 727585 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 358152 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 40765 | 0.190 |
1 | 30000 | 0.175 |
15 | 856516 | 0.170 |
20 | 1438744 | 0.165 |
32 | 1414529 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 228 | 1 |
0.175 | 207666 | 2 |
0.180 | 778991 | 12 |
0.185 | 1482982 | 13 |
0.190 | 1049129 | 11 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
STX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online